EC Number |
Inhibitors |
Structure |
---|
3.1.4.39 | (5Z)-2-(4-ethylpiperazin-1-yl)-5-(4-fluorobenzylidene)-1,3-thiazol-4(5H)-one |
93.8% inhibition at 0.01 mM |
|
3.1.4.39 | (5Z)-2-(azepan-1-yl)-5-(4-propoxybenzylidene)-1,3-thiazol-4(5H)-one |
96.6% inhibition at 0.01 mM |
|
3.1.4.39 | (5Z)-2-(morpholin-4-yl)-5-[4-(pentyloxy)benzylidene]-1,3-thiazol-4(5H)-one |
93.3% inhibition at 0.01 mM |
|
3.1.4.39 | (5Z)-3-benzyl-5-[(1,3-dimethyl-2-oxo-2,3-dihydro-1H-benzimidazol-5-yl)methylidene]-1,3-thiazolidine-2,4-dione |
- |
|
3.1.4.39 | (5Z)-5-(2-chlorobenzylidene)-2-(4-methylpiperazin-1-yl)-1,3-thiazol-4(5H)-one |
96.1% inhibition at 0.01 mM |
|
3.1.4.39 | (5Z)-5-(3,4-dichlorobenzylidene)-2-(4-methylpiperazin-1-yl)-1,3-thiazol-4(5H)-one |
10.5% inhibition at 0.01 mM |
|
3.1.4.39 | (5Z)-5-(3,4-dichlorobenzylidene)-2-(4-methylpiperazin-1-yl)-1,3-thiazol-4(5H)-one |
94.9% inhibition at 0.01 mM |
|
3.1.4.39 | (5Z)-5-(3,4-dichlorobenzylidene)-2-(piperazin-1-yl)-1,3-thiazol-4(5H)-one |
- |
|
3.1.4.39 | (5Z)-5-(3,4-dichlorobenzylidene)-2-[4-[4-(dihydroxymethyl)benzyl]piperazin-1-yl]-1,3-thiazol-4(5H)-one |
- |
|
3.1.4.39 | (5Z)-5-(3,4-dimethoxybenzylidene)-2-[4-(2-hydroxyethyl)piperazin-1-yl]-1,3-thiazol-4(5H)-one |
18.1% inhibition at 0.01 mM |
|